Joseph Robert Pinchman

This inventor holds 26 USPTO granted patents and 24 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Recurium IP Holdings, LLC, Xinthera, Inc., Recurium IP Holding, LLC. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph Robert Pinchman. Retrieved from https://idiyas.com/inventor/joseph-robert-pinchman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 24)

% Patents Active = 88.5

CIPO Patents = 3 (Patent Applications = 26)

EPO Patents = 9 (Patent Applications = 32)

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 20(Granted Patents)

Company Filing History:

19 out of 30

Recurium IP Holdings, LLC

Recurium IP Holding, LLC

patent

4. 1 out of 3

Zeno Royalties & Milestones, LLC

patents

Years Active: 2019-2025

Loading Chart...

Areas of Expertise:

Benzamide Compounds

PARP1 Inhibitors

EGFR Inhibitors

Substituted Pyridines

Analgesic Compounds

Estrogen Receptor Modulators

Bicyclic Compounds

Spirocyclic Compounds

Continuous Flow Processes

Cross Coupling

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE50643 - Benzamide compounds (2025-10-21),

2. 12421241 - Substituted pyridines as PARP1 inhibitors (2025-09-23),

3. 12384780 - PARP1 inhibitors and uses thereof (2025-08-12),

4. 12049460 - EGFR inhibitor compounds (2024-07-30),

5. 12006322 - Substituted pyridines as PARP1 inhibitors (2024-06-11),

6. 11939329 - PARP1 inhibitors and uses thereof (2024-03-26),

7. 11813260 - Benzamide compounds (2023-11-14),

8. 11813259 - Benzamide compounds (2023-11-14),

9. 11795173 - Substituted pyridines as PARP1 inhibitors (2023-10-24),

10. 11724971 - Process for making [1.1.1]propellane (2023-08-15),

11. 11590126 - Benzamide compounds (2023-02-28),

12. 11344546 - Benzamide compounds (2022-05-31),

13. 11339103 - Continuous flow processes for making bicyclic compounds (2022-05-24),

14. 11318134 - Benzamide compounds (2022-05-03),

15. 11242327 - Analgesic compounds (2022-02-08),

Title: Profile of Innovator Joseph Robert Pinchman

Introduction

Joseph Robert Pinchman is a notable inventor based in San Diego, California. He has garnered recognition for his significant contributions to the field of pharmaceuticals, specifically in developing compounds that target cancer treatment. With a prolific portfolio of 23 patents, his work aims to provide innovative solutions for improving health outcomes.

Latest Patents

Among his latest patents, Pinchman has developed compounds known as EGFR inhibitor compounds. These nitrogen-containing bicyclic compounds, including their pharmaceutically acceptable salts, are designed for pharmaceutical compositions and methods aimed at ameliorating and treating cancer. Additionally, he has contributed to the field with substituted pyridines, identifying tricyclic PARP1 inhibitors. The latter compounds and their compositions are recognized for their potential in treating cancer as well.

Career Highlights

Throughout his career, Joseph Pinchman has worked with esteemed organizations, including Recurium IP Holdings, LLC and Xinthera, Inc. His innovative contributions have been instrumental in advancing pharmaceutical research and development.

Collaborations

Collaborating with talented professionals has been a hallmark of Pinchman's career. Notably, he has worked alongside Kevin Duane Bunker and Peter Qinhua Huang, sharing insights and expertise to further their joint endeavors in cancer research.

Conclusion

Joseph Robert Pinchman's impressive array of patents and collaborations highlights his dedication to innovation in the pharmaceutical industry. As he continues to explore new avenues for cancer treatment, his work exemplifies the importance of research and invention in improving healthcare solutions.

Profile summary based on public USPTO records.